These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1. Talmont F; Moulédous L Naunyn Schmiedebergs Arch Pharmacol; 2014 May; 387(5):427-31. PubMed ID: 24458374 [TBL] [Abstract][Full Text] [Related]
6. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3. Tölle M; Klöckl L; Wiedon A; Zidek W; van der Giet M; Schuchardt M Biochem Biophys Res Commun; 2016 Aug; 476(4):627-634. PubMed ID: 27282481 [TBL] [Abstract][Full Text] [Related]
7. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis. Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445 [TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate-induced Flk-1 transactivation stimulates mouse embryonic stem cell proliferation through S1P1/S1P3-dependent β-arrestin/c-Src pathways. Ryu JM; Baek YB; Shin MS; Park JH; Park SH; Lee JH; Han HJ Stem Cell Res; 2014 Jan; 12(1):69-85. PubMed ID: 24145189 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis. Sic H; Kraus H; Madl J; Flittner KA; von Münchow AL; Pieper K; Rizzi M; Kienzler AK; Ayata K; Rauer S; Kleuser B; Salzer U; Burger M; Zirlik K; Lougaris V; Plebani A; Römer W; Loeffler C; Scaramuzza S; Villa A; Noguchi E; Grimbacher B; Eibel H J Allergy Clin Immunol; 2014 Aug; 134(2):420-8. PubMed ID: 24679343 [TBL] [Abstract][Full Text] [Related]
10. An IgM-kappa rat monoclonal antibody specific for the type 1 sphingosine 1-phosphate G protein-coupled receptor with antagonist and agonist activities. Goetzl EJ; Dembrow D; Van Brocklyn JR; Gráler M; Huang MC Immunol Lett; 2004 Apr; 93(1):63-9. PubMed ID: 15134901 [TBL] [Abstract][Full Text] [Related]
15. Type 1 sphingosine 1-phosphate G protein-coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino-terminal tyrosines. Fieger CB; Huang MC; Van Brocklyn JR; Goetzl EJ FASEB J; 2005 Nov; 19(13):1926-8. PubMed ID: 16148028 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P. Kohno T; Igarashi Y Genes Cells; 2008 Jul; 13(7):747-57. PubMed ID: 18513330 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation. Messias CV; Santana-Van-Vliet E; Lemos JP; Moreira OC; Cotta-de-Almeida V; Savino W; Mendes-da-Cruz DA PLoS One; 2016; 11(1):e0148137. PubMed ID: 26824863 [TBL] [Abstract][Full Text] [Related]
18. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P. Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496 [TBL] [Abstract][Full Text] [Related]